Mature B-Cell Non-Hodgkin Lymphoma — Trials

Mature B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

2,506 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 792
Recruiting: 401
Ph III recruiting: 40
Growth YoY: +8%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (393)

clinicaltrialsPublishedShowing 601–650 of 911 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06829771	Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma	recruiting	Phase 1 / Phase 2	90	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY	1	Jan 30, 2026	clinicaltrials
NCT04745559	Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy	active not recruiting	Phase 2	26	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Jan 29, 2026